Graves disease eye damage: new clues from inflammation and thyroid markers

NCT ID NCT07480720

Recruiting now Knowledge-focused Sponsor: Elazıg Fethi Sekin Sehir Hastanesi Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 100 people with Graves disease to see if inflammation and thyroid antibodies are linked to changes in the eye's nerve layer and macula. Researchers will compare eye scans (OCT) and blood tests between patients with and without eye involvement, plus healthy controls. The goal is to better understand how Graves disease affects the eyes, which may help with early detection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better understand how Graves disease affects the eyes, potentially leading to earlier detection of eye problems.
What could go wrong: This is an observational study, not a treatment trial. It only looks at past records, so it cannot prove cause and effect. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endocrine exophthalmos Graves disease Graves Ophthalmopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GRAVES DISEASE GRAVES OPHTHALMOPATHY

Contacts and locations

Locations

Fethi Sekin City Hospital
RECRUITING

Elâzığ, Elaziğ, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.